Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02374411 · ClinicalTrials.gov registry record
Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients
A clinical trial, sponsored by Edward Hospital.
- Completed
- Registry status
- 55
- Enrollment target
NCT02374411: Completed study, sponsored by Edward Hospital.
NCT02374411 is a clinical trial that has completed, run by Edward Hospital. The registered enrollment target is 55 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02374411 has completed, sponsored by Edward Hospital.
- COMPLETED
- Registry status
- 55 participants
- Enrollment target
Study Summary
The goal of this survey of international HIPEC (Hyperthermic Intraperitoneal Chemotherapy) surgeons is to determine their knowledge of and attitudes towards the nutritional support needs of HIPEC patients and what their practice patterns are with this patient population.
Primary Outcome
Questionnaire development was informed by the works of: Karim et al, JPEN 2014 Mar 3, \[Epub ahead of print\]; Cahill, et al, Critical Care 2014, 18:R96; Vashi et al, Nutrition Journal 2013, 12:118; and Cahill et al, BMC Health Services Research 2014, 14:197.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-03 |
What the finished NCT02374411 record still lists
NCT02374411 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 55 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02374411 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02374411 about?
NCT02374411 is a clinical study titled "Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients". The goal of this survey of international HIPEC (Hyperthermic Intraperitoneal Chemotherapy) surgeons is to determine their knowledge of and attitudes towards the nutritional support needs of HIPEC patients and what their practice patterns are with this patient population.
What is the current status of trial NCT02374411?
This trial is currently completed. The enrollment target is 55 participants. The study started on 2014-09. Estimated completion is 2015-03.
Who is sponsoring clinical trial NCT02374411?
This trial is sponsored by Edward Hospital, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia